FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July | Rich FXM

FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July

This entry was posted by admin on March 6, 2023 at 2:56 pm

FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July

Medicare has agreed to provide broader coverage once Leqembi receives full FDA approval.

Click here to read the full article

49,826

Like

Save

Tags: Alzheimer&#039s, approval, Biogen&#039s, decision, early, Eisai&#039s, expected, full, July, Leqembi, review, treatment
Categories: Breaking

Comments

Comments are disabled for this post.

Copyright © RichFXM.com. Back to Forex Search